Cardioselective nitric oxide synthase 3 gene transfer protects against myocardial reperfusion injury
Zsolt Szelid(Semmelweis University), Stefan Janssens(Maastricht University), Xiaoshun Liu(Vlaams Instituut voor Biotechnologie), Glenn Marsboom(Johnson & Johnson (United States)), Pieter Vermeersch(Universitair Ziekenhuis Leuven), Frans Van de Werf(KU Leuven), Marijke Pellens(Ghent University), Désiré Collen(Ghent University), Péter Pokreisz(Ghent University), Erik Verbeken, Hilde Gillijns(Ghent University)
Cited by 31
Related Papers
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
|Nature|1996|4.2k
Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both
|New England Journal of Medicine|2003|2.5k
Dabigatran versus Warfarin in Patients with Mechanical Heart Valves
|New England Journal of Medicine|2013|1.5k